📣 VC round data is live. Check it out!

Redcare Pharmacy Valuation Multiples

Discover Redcare Pharmacy's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Yixintang Pharmaceutical, GoodRx, Anhui Huaren Health, Aldawaa Medical Services and more.

Redcare Pharmacy Overview

About Redcare Pharmacy

Redcare Pharmacy NV operates an online pharmacy store. Its product portfolio is focused on prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products. The company's operating segment includes DACH and International. It generates maximum revenue from the DACH segment, which represents income generated from Germany, Austria, and Switzerland. The International segment represents its income generated from Belgium, the Netherlands, France, and Italy.


Founded

2015

HQ

Netherlands

Employees

2.7K

Sectors

Financials (LTM)

Revenue: $4B
EBITDA: $80M

EV

$1B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Redcare Pharmacy Financials

Redcare Pharmacy reported last 12-month revenue of $4B and EBITDA of $80M.

In the same LTM period, Redcare Pharmacy generated $815M in gross profit, $80M in EBITDA, and had net loss of ($37M).

Revenue (LTM)


Redcare Pharmacy P&L

In the most recent fiscal year, Redcare Pharmacy reported revenue of $3B and EBITDA of $67M.

Redcare Pharmacy is unprofitable as of last fiscal year, with gross margin of 23%, EBITDA margin of 2%, and net margin of (1%).

See analyst estimates for Redcare Pharmacy
LTMLast FY202320242025202620272028
Revenue$4B$3B$2B$3B$3B
Gross Profit$815M$772M$513M$636M$772M
Gross Margin23%23%24%23%23%
EBITDA$80M$67M$59M$33M$56M
EBITDA Margin2%2%3%1%2%
EBIT Margin(0%)(1%)(1%)(2%)(1%)
Net Profit($37M)($44M)($14M)($53M)($44M)
Net Margin(1%)(1%)(1%)(2%)(1%)
Net Debt-$287M---

Financial data powered by Morningstar, Inc.

Redcare Pharmacy Stock Performance

Redcare Pharmacy has current market cap of $1B, and enterprise value of $1B.

Market Cap Evolution


Redcare Pharmacy's stock price is $50.56.

Redcare Pharmacy share price decreased by 0.1% in the last 30 days, and by 53.3% in the last year.

Redcare Pharmacy has an EPS (earnings per share) of $-2.16.

See more trading valuation data for Redcare Pharmacy
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1B$1B-0.1%-0.1%12.8%-53.3%$-2.16

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Redcare Pharmacy Valuation Multiples

Redcare Pharmacy trades at 0.4x EV/Revenue multiple, and 16.0x EV/EBITDA.

See NTM and 2027E valuation multiples for Redcare Pharmacy

EV / Revenue (LTM)


Redcare Pharmacy Financial Valuation Multiples

As of June 2, 2026, Redcare Pharmacy has market cap of $1B and EV of $1B.

Redcare Pharmacy has a P/E ratio of (27.7x).

LTMLast FY202320242025202620272028
EV/Revenue0.4x0.4x0.6x0.5x0.4x
EV/EBITDA16.0x19.1x21.5x38.9x22.8x
EV/EBIT(98.3x)(50.4x)(62.2x)(28.1x)(36.8x)
EV/Gross Profit1.6x1.7x2.5x2.0x1.7x
P/E(27.7x)(23.4x)(73.3x)(19.4x)(23.4x)
EV/FCF(17.6x)(12.5x)47.1x(54.7x)(12.5x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Redcare Pharmacy Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Redcare Pharmacy Margins & Growth Rates

Redcare Pharmacy grew revenue by 14% and EBITDA by 47% in the last fiscal year.

In the most recent fiscal year, Redcare Pharmacy reported gross margin of 23%, EBITDA margin of 2%, and net margin of (1%).

See estimated margins and future growth rates for Redcare Pharmacy

Redcare Pharmacy Margins

Last FY202420252026202720282029
Gross Margin23%23%23%22%
EBITDA Margin2%1%2%3%
EBIT Margin(1%)(2%)(1%)0%
Net Margin(1%)(2%)(1%)(1%)
FCF Margin(3%)(1%)(3%)(1%)

Redcare Pharmacy Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth14%32%24%14%
Gross Profit Growth13%24%21%13%
EBITDA Growth47%(45%)71%75%
EBIT Growth(116%)121%(24%)(112%)
Net Profit Growth(43%)278%(17%)(43%)
FCF Growth(76%)(186%)337%(76%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Redcare Pharmacy Operational KPIs

Redcare Pharmacy's revenue per employee in the last FY averaged $1.3M, while opex per employee averaged $0.3M for the same period.

Redcare Pharmacy's Rule of 40 is 16% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Redcare Pharmacy's Rule of X is 37% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Redcare Pharmacy
LTMLast FY202320242025202620272028
Rule of 4015%16%---
Bessemer Rule of X35%37%---
Revenue per Employee-$1.3M---
Opex per Employee-$0.3M---
S&M Expenses to Revenue19%19%13%13%13%
G&A Expenses to Revenue3%3%2%2%2%
R&D Expenses to Revenue0%0%--0%
Opex to Revenue-24%25%25%24%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Redcare Pharmacy Competitors

Redcare Pharmacy competitors include Yixintang Pharmaceutical, GoodRx, Anhui Huaren Health, Aldawaa Medical Services, Medplus Health Services, Shu Yu Civilian Pharmacy, AiN Group, Apotea, Create SD Holdings and Selçuk Ecza.

Most Redcare Pharmacy public comparables operate across Pharmacies.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Yixintang Pharmaceutical0.4x0.4x3.5x6.6x
GoodRx1.7x1.7x5.0x5.3x
Anhui Huaren Health1.4x-11.5x-
Aldawaa Medical Services1.0x0.9x6.9x7.1x
Medplus Health Services1.6x1.6x16.7x18.2x
Shu Yu Civilian Pharmacy0.8x-11.0x-
AiN Group0.6x0.5x9.4x6.3x
Apotea1.1x1.0x16.4x15.1x

This data is available for Pro users. Sign up to see all Redcare Pharmacy competitors and their valuation data.

Start Free Trial

Acquisitions by Redcare Pharmacy

Redcare Pharmacy has acquired 4 companies to date.

Last acquisition by Redcare Pharmacy was on April 12th 2022. Redcare Pharmacy acquired FIRST A for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Redcare Pharmacy

FIRST A
MedApp
smartpatient
nu3
Description
FIRST A is a Berlin-based preorder platform connecting patients to 5,000 German pharmacies for over-the-counter medications in categories like pain relief, allergies, first aid, skincare, vitamins, and herbal remedies. Launched in 2022, GoPuls processes 1 million orders yearly via mobile app, enabling same-day pickup and reducing in-store wait times by 70 percent.
MedApp is a mobile application helping users track medication intake and share records with healthcare providers. Developed in the Netherlands, the platform supports multilingual interfaces and integrates with pharmacy systems for refill reminders and adherence monitoring across chronic disease management.
smartpatient is a Vienna-based digital health firm that operates MyTherapy, a medication adherence app downloaded over 10 million times worldwide. The platform serves as an operating system for digital therapeutics, integrating reminders, health tracking, and care programs for chronic conditions like diabetes and hypertension. Partners in pharmaceuticals and healthcare leverage MyTherapy for patient support initiatives, including customized content from companies such as Novartis and Roche, with features like pill scanners and doctor report generators.
nu3 is a Berlin-headquartered company with operations in Sao Paulo that sells functional foods for weight management, natural supplements, and sports nutrition. Founded in 2011, it offers branded products alongside third-party items, complemented by telephone nutritional coaching and an online blog with dietary guidance in German and Portuguese markets.
HQ CountryGermanyNetherlandsGermanyGermany
HQ City
Berlin
Eindhoven
Munich
Berlin
Deal Date12 Apr 202230 Mar 20217 Jan 202113 Jul 2018
Valuationundisclosedundisclosed$76Mundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Redcare Pharmacy acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Redcare Pharmacy

When was Redcare Pharmacy founded?Redcare Pharmacy was founded in 2015.
Where is Redcare Pharmacy headquartered?Redcare Pharmacy is headquartered in Netherlands.
How many employees does Redcare Pharmacy have?As of today, Redcare Pharmacy has over 2K employees.
Is Redcare Pharmacy publicly listed?Yes, Redcare Pharmacy is a public company listed on Frankfurt Stock Exchange.
What is the stock symbol of Redcare Pharmacy?Redcare Pharmacy trades under RDC ticker.
When did Redcare Pharmacy go public?Redcare Pharmacy went public in 2016.
Who are competitors of Redcare Pharmacy?Redcare Pharmacy main competitors include Yixintang Pharmaceutical, GoodRx, Anhui Huaren Health, Aldawaa Medical Services, Medplus Health Services, Shu Yu Civilian Pharmacy, AiN Group, Apotea, Create SD Holdings, Selçuk Ecza.
What is the current market cap of Redcare Pharmacy?Redcare Pharmacy's current market cap is $1B.
What is the current revenue of Redcare Pharmacy?Redcare Pharmacy's last 12 months revenue is $4B.
What is the current revenue growth of Redcare Pharmacy?Redcare Pharmacy revenue growth (NTM/LTM) is 13%.
What is the current EV/Revenue multiple of Redcare Pharmacy?Current revenue multiple of Redcare Pharmacy is 0.4x.
What is the current EBITDA of Redcare Pharmacy?Redcare Pharmacy's last 12 months EBITDA is $80M.
What is Redcare Pharmacy's EBITDA margin?Redcare Pharmacy's last 12 months EBITDA margin is 2%.
What is the current EV/EBITDA multiple of Redcare Pharmacy?Current EBITDA multiple of Redcare Pharmacy is 16.0x.
What is the current FCF of Redcare Pharmacy?Redcare Pharmacy's last 12 months FCF is ($73M).
What is Redcare Pharmacy's FCF margin?Redcare Pharmacy's last 12 months FCF margin is (2%).
What is the current EV/FCF multiple of Redcare Pharmacy?Current FCF multiple of Redcare Pharmacy is (17.6x).
How many companies Redcare Pharmacy has acquired to date?As of June 2026, Redcare Pharmacy has acquired 4 companies.
What was the largest acquisition by Redcare Pharmacy?$76M acquisition of smartpatient on 7th January 2021 was the largest M&A Redcare Pharmacy has done to date.
What companies Redcare Pharmacy acquired?Redcare Pharmacy acquired smartpatient, nu3, MedApp, and FIRST A.
In how many companies Redcare Pharmacy has invested to date?Redcare Pharmacy hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Redcare Pharmacy

Lists including Redcare Pharmacy

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial